Choose language
< Return to main menu
h01pcban.jpg 手机2-624.jpg

Small Molecule

Services & Solutions

Services & Solutions

News & Events

Career

Small Molecule

Small Molecule

WuXi TIDES(Oligonucleotide and Peptide CRDMO Service)

C“R”DMO

01.png

Research Chemistry Services

WuXi AppTec's Research Chemistry Services (RCS) is a global leading chemistry platform offering synthetic and medicinal chemistry solutions to pharmaceutical and biotech companies, as well as research institutes and non-profit foundations worldwide. As an integrated small molecule drug discovery platform, RCS provides both Full-time Equivalent (FTE) and Fee-for-Service (FFS) models, aimed at streamlining the drug discovery process, with emphasis on productivity, speed, flexibility, quality and reliability.

Capabilities and Capacity

l_c1icon1.svg
20+ years’ experience
l_c1icon2.svg
7 research sites worldwide
l_c1icon3.svg
1300+ global clients

20 of global top 20 pharmaceutical companies

516 clients have FTE collaboration

27 clients with 50+ FTE team including: 13 clients with 100+ FTE teams

686 clients with >5 years' collaboration including: 162 clients with >10 years' collaboration

FFS collaboration covers 1,200+ customers from mg to kg scale synthesis

11,000+ Regular FFS Projects per year, > 95% on time delivery rate

2,000+ DPC (Discovery Process Chemistry) Projects per year

Consistently high customer satisfaction (Net Promoter Score >90)

CR“DM”O

02.png

WuXi STA: Development and Manufacturing Service

WuXi STA, a subsidiary of WuXi AppTec, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with global operations.

As a premier Contract Development and Manufacturing Organization (CDMO), WuXi STA offers our worldwide partners efficient, flexible and high-quality solutions for integrated CMC (Chemical, Manufacturing, and Control) from preclinical to commercial.

Capabilities and Capacity

Integrated CMC platform for both API and drug product

9 development and manufacturing sites worldwide with one quality and EHS standard approved by all major regulatory agencies

Supported 50+ first-time new drugs approved in the US, Europe, China and Japan since 2017, 105 country approvals for branded drugs

Industry leading teams:  3,400+ process chemists & analytical scientists for API platform;  1,500+ formulation scientists & analytical scientists for drug product platform